Review article

Specific reversal agents in acute stroke

Senta Frol ; Dept of Vascular Neurology, University Medical Center Ljubljana, Ljubljana, Slovenia *

* Corresponding author.

Abstract

Direct oral anticoagulants (DOACs) are first line therapy in primary and secondary stroke prevention in patients with non-valvular atrial fibrillation. Regardless of their use a minority of patients still suffer acute stroke (ischemic or hemorrhagic). Specific reversal agents changed concept of therapy in DOAC-treated patients with acute stroke. In this manuscript data on randomized controlled trials, real-world evidence and proposed standard operating procedures are summarized.

Keywords

specific reversal agents; acute stroke

Hrčak ID:

318619

URI

https://hrcak.srce.hr/318619

Publication date:

25.6.2024.

Visits: 0 *